HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain.

Abstract
Gamma-aminobutyric acid (GABA) receptors are ubiquitous inhibitory receptors in the central and peripheral nervous systems. Valproic acid (2-propylpentanoic acid), which enhances GABA synthesis and blocks degradation, is useful in migraine treatment and may act through activation of GABA receptors to modulate trigeminal nociceptive neurons innervating the meninges. To investigate this possibility, we tested the effect of valproate and allopregnanolone, a metabolite of progesterone, which binds and modulates the GABA receptor in an animal model of cephalic pain. One hundred ten Hartley guinea pigs were pretreated with either valproate or allopregnanolone 30 minutes prior to activation of trigeminal afferent fibers via intracisternal injection of the irritant, capsaicin. The effects of valproic acid and allopregnanolone were examined on c-fos expression within the trigeminal nucleus caudalis (lamina I, II), the termination site for small unmyelinated C fibers projecting from the meninges. C-fos positive cells were counted at three representative levels (rostral, middle, and caudal) by an observer naive to the treatment group. We found that valproate (> or = 10 mg/kg, IP) reduced labeled cells by 52% (P < 0.05) and allopregnanolone (> or = 100 mg/kg, IP) reduced labeled cells by 42% (P < 0.01). Bicuculline (GABAA antagonist), but not phaclofen (GABAB antagonist), blocked the valproate effect, thereby documenting the importance of GABAA receptors. We conclude that the attenuation of c-fos-LI by valproate and allopregnanolone is mediated via GABAA receptors. These studies complement prior experiments showing that valproic acid and allopregnanolone block neurogenic inflammation within the meninges via GABAA receptor-mediated mechanisms. The findings suggest a potential strategy for discovering new antimigraine drugs with high affinity for the GABAA receptor and its modulatory sites.
AuthorsF M Cutrer, M A Moskowitz
JournalHeadache (Headache) 1996 Nov-Dec Vol. 36 Issue 10 Pg. 579-85 ISSN: 0017-8748 [Print] United States
PMID8990596 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • GABA Agents
  • GABA Modulators
  • Receptors, GABA
  • Valproic Acid
  • Pregnanolone
  • Capsaicin
Topics
  • Animals
  • Capsaicin
  • Disease Models, Animal
  • GABA Agents (pharmacology)
  • GABA Modulators (pharmacology)
  • Gene Expression (drug effects)
  • Genes, fos (drug effects, genetics)
  • Guinea Pigs
  • Headache (physiopathology)
  • Male
  • Pain (physiopathology)
  • Pregnanolone (pharmacology)
  • Receptors, GABA (drug effects)
  • Valproic Acid (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: